BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25511212)

  • 21. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma.
    Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2013 Mar; 41(3):212-7. PubMed ID: 21965052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters.
    Mitselou A; Ioachim E; Zagorianakou N; Kitsiou E; Vougiouklakis T; Agnantis NJ
    Eur J Gynaecol Oncol; 2004; 25(6):719-24. PubMed ID: 15597850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
    Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
    Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
    Choudhury M; Bansal S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Cyclin D1 in Hyperplasia and Carcinoma of Endometrium and Its Correlation with Histologic Grade, Tumor Type, and Clinicopathological Features.
    Sangwan K; Garg M; Pathak N; Bharti L
    J Lab Physicians; 2020 Dec; 12(3):165-170. PubMed ID: 33268933
    [No Abstract]   [Full Text] [Related]  

  • 30. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
    Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
    Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
    Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
    J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
    Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
    Gurda GT; Baras AS; Kurman RJ
    Int J Gynecol Pathol; 2014 Mar; 33(2):114-9. PubMed ID: 24487464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
    Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
    Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
    Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
    Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
    Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
    Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.